| Decision | Consent granted Section 13(1)(c) Overseas Investment Act 2005 |
|---|---|
| Decision Maker | Overseas Investment Office |
| Decision Date | 4 March 2022 |
| Pathway(s) | Significant business assets only |
| Investment | The acquisition of up to 100% of the shares in Tāmaki Health Group Limited |
| Asset Value | $77,000,000 |
| Applicant | Mercury Medical Holdings Limited New Zealand (72.00%) United States of America (24.00%) Australia (4.00%) |
| Vendor | Nirvana Family Partnership LP New Zealand (100.00%) |
| Background | Tāmaki Health Group Limited (THGL) is the largest independent primary healthcare group in New Zealand, serving 230,000 enrolled patients across 45 clinics. THGL is the largest provider of urgent care and general practice clinics in New Zealand. THGL employs 1000 staff while providing affordable and accessible healthcare to vulnerable communities. In 2017, the Applicant obtained OIO consent to acquire an approximately 50% stake in THGL (Case 201620106). The Applicant is now seeking consent to acquire an up to 100% interest in THGL. The Applicant has satisfied the OIO that the individuals who will control the investment are suitable persons to invest in New Zealand. |
| More information | Haydn Wong Bell Gully (Auckland) Level 21, Vero Centre 48 Shortland Street Auckland 1010 |